New U.S. Amnesty Law Trips Foreign Students

BOSTON—Thousands of scientists and engineers who have been in the United States illegally over the past decade after arriving as students may not be able to gain amnesty under an interpretation of the new immigration law by Immigration and Naturalization Service (INS) officials. The law, which promised amnesty to foreigners living illegally in this country since before 1982, is being applied "very liberally" to those who entered the country illegally—primarily undocumented workers fr

Written bySeth Shulman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The law, which promised amnesty to foreigners living illegally in this country since before 1982, is being applied "very liberally" to those who entered the country illegally—primarily undocumented workers from Central America who have taken menial and migrant jobs here, according to various sources. But many experts believe that educated aliens—many of whom are scientists and engineers—are being discriminated against by the new laws.

Carolyn Fuchs, a Boston-based attorney who focuses exclusively on immigration law, cited the cases of two clients, both of whom requested anonymity, to demonstrate the vagaries of the new law. Each came to the United States in the late 1970s from Hong Kong and graduated in 1981.

One client, Tim, was asked by a hospital to do medical research on AIDS and came to Fuchs to obtain a work permit through proper channels. Fuchs has handled the renewal of his work permit every year since then. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies